Company Filing History:
Years Active: 1998
Title: Junichi Tsukada: Innovator in DNA Binding Research
Introduction
Junichi Tsukada is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of molecular biology, particularly in understanding the interactions between proteins and nucleic acids. His innovative work has led to the development of a patent that addresses important biological processes.
Latest Patents
Junichi Tsukada holds a patent for "LIL-Stat DNA binding sites and methods for identifying inhibitory." This patent describes a method for finding an agent that inhibits the interaction between the LIL-Stat protein and a nucleic acid with a LIL-Stat binding sequence. The process involves contacting the LIL-Stat protein with the nucleic acid in the presence of an agent that may inhibit this interaction. The effectiveness of the agent in inhibiting the interaction is then determined. Additionally, the patent outlines methods for treating inflammatory responses in mammals, therapeutic agents suitable for such treatments, and DNA molecules encoding binding sites for the LIL-Stat protein.
Career Highlights
Junichi Tsukada is affiliated with the Center for Blood Research, Inc., where he continues to advance research in his field. His work has implications for therapeutic strategies in treating inflammatory conditions, showcasing his commitment to improving health outcomes through scientific innovation.
Collaborations
Throughout his career, Tsukada has collaborated with esteemed colleagues, including Philip E. Auron and Wayne R. Waterman. These partnerships have fostered a collaborative environment that enhances research productivity and innovation.
Conclusion
Junichi Tsukada's contributions to the field of molecular biology, particularly through his patent on LIL-Stat DNA binding sites, highlight his role as an influential inventor. His work not only advances scientific understanding but also has the potential to lead to new therapeutic approaches for inflammatory diseases.